Industry groups seek changes to FDA’s remote interactive evaluation guidance
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesChemistry, Manufacturing and Controls (CMC)CompliancePharmaceuticalsRegulatory Intelligence/PolicyRegulatory writing/documentationUnited States